What are the risks of investing in RZLT?
R
What are the risks of investing in RZLT?
🦉
Rezolute, Inc. (RZLT)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEONevan Charles Elam
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the...
Key Executives
| Name | Title |
|---|---|
| Brian Kenneth Roberts | Chief Medical Officer |
| Chris Milks | Vice President & Head of Finance |
| Daron G. Evans | Chief Financial & Business Officer |
| Davelyn Eaves Hood | Director and Head of Scientific & Patient Affairs |
| Erin O'Boyle | Senior Vice President & Head of Clinical Operations |
| Melissa Quinn | Senior Director of People and Culture |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A